Article
Zinc supplements for treating thalassaemia and sickle cell disease
27 Jun 2013
Abstract excerpt
BACKGROUND: Haemoglobinopathies, inherited disorders of haemoglobin synthesis (thalassaemia) or structure (sickle cell disease), are responsible for significant morbidity and mortality throughout the world. The WHO estimates that, globally, 5% of adults are carriers of a haemoglobin condition, 2.9% are carriers of thalassaemia and 2.3% are carriers of sickle cell disease. Carriers are found worldwide as a result...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
